Ausgabe 1/2012
Special focus on immunotherapy
Inhalt (7 Artikel)
Recent successes of cancer immunotherapy: a new dimension in personalized medicine?
Christophe Caux, Laurence Zitvogel
Adoptive transfer with high-affinity TCR to treat human solid tumors: how to improve the feasibility?
F. Jotereau, N. Gervois, N. Labarrière
Targeting regulatory T cells
Christine Ménétrier-Caux, Tyler Curiel, Julien Faget, Manuarii Manuel, Christophe Caux, Weiping Zou
Targeting pattern recognition receptors in cancer immunotherapy
Nadège Goutagny, Yann Estornes, Uzma Hasan, Serge Lebecque, Christophe Caux
Interleukin-7 and immune reconstitution in cancer patients: a new paradigm for dramatically increasing overall survival
Michel Morre, Stéphanie Beq
A review on various targeted anticancer therapies
Junjie Li, Feng Chen, Marlein Miranda Cona, Yuanbo Feng, Uwe Himmelreich, Raymond Oyen, Alfons Verbruggen, Yicheng Ni
Advancement in the research on vascular endothelial growth inhibitor (VEGI)
Lijiao Duan, Ganggang Yang, Ruigang Zhang, Lijuan Feng, Cunshuan Xu